Indo US Bio-Tech Ltd Share Price

Q: What is the share price of Indo US Bio-Tech Ltd today?

Indo US Bio-Tech Ltd share price as on 31 Jan 2025 is ₹220

Miscellaneous - Medium / Small

NSE: INDOUS Small Cap ISIN: INE250Z01010

As on 31 January 2025 at 14:07 IST

₹220

+ 1.35

(0.62%)

Sell Buy

Over 1 Month

-29.80%

Over 6 Months

-25.27%

Over 1 Year

Over 3 Years

Indo US Bio-Tech Ltd Summary

Close ₹ 220

Open ₹ 224.95

High ₹ 224.95

Low ₹ 208.05

Volume 681

Net Turnover (in ₹ Cr) ₹ 0.12

52Wk High ₹ 388.40

52Wk Low ₹ 192

52Wk High / Low

192

388.40

Indo US Bio-Tech Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 438.44

EPS (TTM) 7.69

Book Value (BV) 35.04

Div. Yield -

P/E (TTM) 28.54

Price/Book Value 6.27

Delivery % -

Face Value 10

Key Ratios

PE Ratio 54

PB Ratio 7.09

EV to Sales 6.29

PEG Ratio -1.25

ROA 10.51

ROE 14.07

Debt-Equity 0.22

Net Profit Margin 11.33

Operating Profit Margin 15.27

Indo US Bio-Tech Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Total Revenue	50.24	40.15	39.77	-	-
Total Expenses	44.93	36.22	36.90	-	-
Profit Before Tax	5.31	3.93	2.86	-	-
Profit After Tax	5.06	4.90	2.53	-	-
Operating Profit after Depreciation	6.49	5.09	3.72	-	-

Balance Sheet

Particulars (in ₹ Cr.)	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Fixed Assets	5.55	2.37	1.41	-	-
Total Non Current Assets	8.78	5.57	2.80	-	-
Total Current Assets	46.84	38.13	31.90	-	-
TOTAL ASSETS	55.62	43.71	34.70	-	-
Total Shareholder's Fund	38.51	21.34	16.44	-	-

Cash Flow

Particulars (in ₹ Cr.)	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Net Cash from Operating Activities	2.70	0.16	-0.84	-	-
Net Cash used in Investing Activities	-5.44	-1.78	-0.57	-	-
Net Cash used in Financing Activities	2.65	1.55	1.53	-	-

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	73.16	61.77	50.24	40.13	39.77
Total Expenses	64.35	54.38	44.75	36	36.90
Profit Before Tax	8.80	7.39	5.49	4.13	2.86
Profit After Tax	8.25	7.24	5.24	5.10	2.53
Operating Profit after Depreciation	10.31	8.57	6.67	5.29	3.72

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	6.69	7.37	5.54	2.33	1.41
Total Non Current Assets	11.36	9.56	8.52	5.55	2.80
Total Current Assets	73.09	59.91	47.06	38.13	31.90
TOTAL ASSETS	84.46	69.47	55.57	43.68	34.70
Total Shareholder's Fund	62.75	54.50	38.88	21.54	16.44

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	-4.58	0.53	2.91	0.22	-0.84
Net Cash used in Investing Activities	4.28	-6.67	-5.40	-1.75	-0.57
Net Cash used in Financing Activities	1.22	6.29	2.41	1.46	1.53

No data available

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	22.17	24.72	37.88	22.11	15.81
Total Expenses	17.05	21.03	32.67	17.87	13.22
Profit Before Tax	4.44	3.19	4.38	3.76	1.97
Profit After Tax	4.36	3.17	4.21	3.68	1.67
Operating Profit after Depreciation	5.14	3.72	5.50	4.32	2.59

Indo US Bio-Tech Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 211.78

S2 204.92

S3 199.83

Pivot 216.87

R1 223.73

R2 228.82

R3 235.68

Moving Average

20 SMA 237.82

50 SMA 278.91

100 SMA -

200 SMA -

Indo US Bio-Tech Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

Indo US Bio-Tech Ltd

₹0.25/Share

Announcement Date 03 Dec 2024

Record Date 03 Dec 2024

Div Yield 2.5%

AGM Date: 01 Aug 2022

AGM 01/08/2022 In reference with above subject, and advance intimation in the matter, the Board met today, discussed and resolved the agendas mentioned in the attached document. The Meeting commenced at 16.30 Hrs and concluded at 17:30 Hrs. Do acknowledge the receipt of same. Disseminate the above announcement on BSE's Website. (As Per BSE Announcement dated on 08.07.2022) In reference to the captioned subject, it had come to knowledge of Management, post sending the notice, that addition / alteration of certain details and information in the original Notice would make it more convenient for stakeholders and members to take an informed decision and to apprise the facts and nitty gritty of the agenda proposed in the ensuing meeting. Thus, the management of the Company have concluded to issue an addendum to the erstwhile notice for information and perusal by the members. The said addendum is being sent to the members via e-mail. A copy of said addendum is enclosed herewith for your records and information please. Request you to kindly disseminate the same on website of Exchange for prompt information of our stakeholders. (As Per BSE Announcement Dated 14.07.2022) In reference to the captioned subject, it had come to knowledge of Management, post sending the notice and Addendum to the Notice, that addition / alteration of certain details and information in the original Notice and Addendum would make it more convenient for stakeholders and members to take an informed decision and to apprise the facts and nitty gritty of the agenda proposed in the ensuing meeting. Thus, the management of the Company have concluded to issue 2nd addendum to the erstwhile notice for information and perusal by the members. The said 2nd addendum is being sent to the members via e-mail. A copy of said 2nd addendum is enclosed herewith for your records and information please. Request you to kindly disseminate the same on website of Exchange for prompt information of our stakeholders. (As Per BSE Announcement Dated on 20.07.2022) Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed the details of voting results with respect to 18thAnnual General Meeting of the Company held on Monday, 1st August, 2022 at 11:30 a.m. at through electronic mode (video conference or other audio-visual means) as per the format prescribed. please find enclosed, for your records the report issued by the Scrutinizer i.e., Mr. AMRISH GANDHI, FCS Proprietor of M/ s. AMRISH GANDHI & Associates, Company Secretaries We request you to take the aforesaid on records. Thanking you, Indo Us Bio-Tech Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 02.08.2022)

AGM Date: 30 Sep 2023

Notice of 19th Annual General Meeting (AGM) in English and Gujarati Newspaper. Outcome of Board Meeting (As Per BSE Announcement dated on 07.09.2023) Voting Results and Scrutinizer''s Report. (As Per BSE Announcement dated on 03.10.2023) With reference to captioned subject we would like to draw your attention that in the Annual Report of 2022-23 the figure was wrongly mentioned and hence we have updated the same. Further we would like to inform that it was clerical error which was unintentional and not deliberate. Moreover it do not have any imapct on profitability of the Company. (As Per BSE Announcement Dated on 19/04/2024)

AGM Date: 30 Sep 2024

AGM 30/09/2024 Gist of Proceedings of 20th Annual General Meeting. (As Per Bse Announcement Dated on 30.09.2024)

EGM Date: 25 May 2022

This is to inform you that, the Board of Directors at their Meeting held on today i.e., 2nd Day of May, 2022 at 4:00 P.M. at the registered office of the Company, had considered and approved the following: 1. Calling of Extra Ordinary General Meeting (EGM) on 25.05.2022 at 11.00 am to approve the agenda(s) through VC/ OAVM to comply regulation 170(2) of SEBI ICDR for according fresh approval to allotment of 18,85,112 equity shares on Preferential allotment basis by the members, for which approval of Board was given in their meeting convened on 21.03.2022, but was time barred and thus fresh approval of same was mandated by Exchange. 2. Approve the draft notice of Extra-Ordinary General Meeting (EGM) held on 25.05.2022. 3. Appointment of M/s A. Santoki & Associates as a Scrutinizer of the Extra Ordinary General Meeting (EGM). 4. The e-voting period shall commence from 22/05/2022, 9:00 AM to 24/05/2022, 5:00 PM. 5. Any other business with the permission of the Board Chair. Pursuant to Regulation 30(6) and Part A of Schedule III of Securities Exchange board of India (Listing Obligations and Disclosures requirements) Regulations, 2015, we hereby enclose herewith Notice along with e-voting instructions of Extra Ordinary General Meeting (EGM) of the company which is scheduled to be held on Wednesday, 25th May, 2022 at 11.00 a.m. through Video Conferencing ('VC')/ Other Audio-Visual Means ('OAVM'). You are requested to take the same on your record. Thanking You. (As Per BSE Announcement Dated on 03.05.2022) In reference to the captioned subject, it had come to knowledge of Management, post sending the notice, that addition / alteration of certain details and information in the original Notice would make it more convenient for stakeholders and members to take an informed decision and to apprise the facts and nitty gritty of the agenda proposed in the ensuing meeting. Thus, the management of the Company have concluded to issue an addendum to the erstwhile notice for information and perusal by the members. The said addendum is being sent to the members via e-mail. A copy of said addendum is enclosed herewith for your records and information please. Request you to kindly disseminate the same on website of Exchange for prompt information of our stakeholders. Thanking You, (As Per BSE Announcement Dated on 10.05.2022) In reference to the captioned subject, the Management hereby has resolved and approved to make changes to few typographical errors in Addendum and to Notice of EGM. Thus, the management of the Company have concluded to issue second addendum to the erstwhile notice and first addendum for information and perusal by the members. The said addendum is being sent to the members via e-mail. A copy of said addendum is enclosed herewith for your records and information please. Request you to kindly disseminate the same on website of Exchange for prompt information of our stakeholders. Thanking You, (As Per BSE Announcement dated on 11.05.2022) With reference to above captioned manner and in compliance with the regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''''''''The Listing Regulations''''''''), we are enclosing herewith the proceedings of Extra Ordinary General Meeting of the Members held on today i.e. Wednesday, 25th Day of May, 2022 at 11.02 a.m. through video conferencing and other audio-visual means. Please take the same on your record. (As Per BSE Announcement Dated on 25.05.2022) Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed the details of voting results with respect to Extra Ordinary General Meeting of the Company held on Wednesday, 25th Day of May, 2022 at 11:02 a.m. at through electronic mode (video conference or other audio-visual means) as per the format prescribed. Further, the results are also being uploaded on website of the Company at https://www.indousagriseeds.com/ Also, please find enclosed, for your records the report issued by the Scrutinizer i.e., Mr. Ajit Santoki, FCS Proprietor of M/s. A. Santoki & Associates, Company Secretaries We request you to take the aforesaid on records. Thanking you, (As Per BSE Announcement Dated on 26/05/2022) Indo Us Bio-Tech Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As per BSE Announcement Dated on 27/5/2022)

Indo US Bio-Tech Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Indo US Bio-Tech Ltd	₹219.50	₹440.14
Hindustan Unilever Ltd	₹2,411.60	₹5,66,627.43
Nestle India Ltd	₹2,218.75	₹2,13,922.37
Varun Beverages Ltd	₹541	₹1,82,939.69
Britannia Industries Ltd	₹5,079.65	₹1,22,352.66
Godrej Consumer Products Ltd	₹1,118.90	₹1,14,464.35

Indo US Bio-Tech Ltd News

Indo US Bio-Tech Ltd leads gainers in 'B' group

One Mobikwik Systems Ltd, Captain Pipes Ltd, Incredible Industries Ltd and DC Infotech & Communication Ltd are among the other gainers in the BSE's 'B' group today, 26 December 2024.

26 Dec 2024, 12:15 pm

Board of Indo US Bio-Tech recommends Interim Dividend

Of Rs.0.25 per share

21 Nov 2024, 11:59 am

Indo US Bio-Tech revises board meeting date

To 21 November 2024

13 Nov 2024, 05:35 pm

Indo US Bio-Tech to consider Interim Dividend

On 16 November 2024

13 Nov 2024, 04:56 pm

Indo US Bio-Tech announces board meeting date

On 14 November 2024

07 Nov 2024, 02:23 pm

Indo US Bio-Tech Ltd Stock Analysis

Annual revenue for Indo US Bio-Tech Ltd increased by 18.44% to ₹73.16 crore in FY 2024 from ₹61.77 crore in FY 2023.
Annual Net Profit for Indo US Bio-Tech Ltd increased by 13.96% to ₹8.25 crore in FY 2024 from ₹7.24 crore in FY 2023.
Promoter Shareholding in Indo US Bio-Tech Ltd remains unchanged by 0.00% in the most recent quarter, from 70.17% in September 2024 to 70.17% in December 2024.
Indo US Bio-Tech Ltd delivered a 1-year return of 0% compared to the Nifty 50, which provided a return of 8.03% as of the last trading session.
Indo US Bio-Tech Ltd share price moved up by 0.62% from its previous close of INR ₹218.65. The latest Indo US Bio-Tech Ltd share price is INR ₹220.
Indo US Bio-Tech Ltd share price today has been at a low of 208.05 and a high of 224.95. Over the past 52 weeks, the Indo US Bio-Tech Ltd share price has seen a low of 192 and a high of 388.40.